Esovax DSR capsule is a combination medication containing Domperidone 30mg and Esomeprazole 40mg, designed to effectively manage gastrointestinal disorders related to acid reflux and delayed gastric emptying. Domperidone, a dopamine antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby alleviating symptoms such as nausea, vomiting, bloating, and discomfort associated with delayed gastric emptying. Esomeprazole, a proton pump inhibitor, works by reducing the production of stomach acid, providing relief from acid-related conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. The dual action of Esovax DSR addresses both the excessive acid secretion and impaired gastric motility, offering comprehensive symptomatic relief. This combination is particularly beneficial for patients experiencing persistent heartburn, regurgitation, and upper abdominal pain. Esovax DSR should be taken as prescribed by a healthcare professional, typically before meals, to maximize its efficacy. Patients with known hypersensitivity to either component or those with certain cardiac conditions should use this medication cautiously. Overall, Esovax DSR capsule provides an effective therapeutic option for managing complex gastrointestinal symptoms by combining acid suppression with prokinetic activity.